Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Best Growth Stocks to Buy for December 31st
05:55am, Wednesday, 31'st Dec 2025
GLDD, CIEN and PODD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 31, 2025.
Osaic Holdings Inc. Purchases 5,309 Shares of Insulet Corporation $PODD
05:13am, Saturday, 27'th Dec 2025
Osaic Holdings Inc. boosted its position in Insulet Corporation (NASDAQ: PODD) by 152.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
3 Reasons Growth Investors Will Love Insulet (PODD)
01:46pm, Friday, 26'th Dec 2025
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:46am, Monday, 22'nd Dec 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Central Pacific Bank Trust Division Reduces Stock Holdings in Insulet Corporation $PODD
03:54am, Thursday, 18'th Dec 2025
Central Pacific Bank Trust Division lowered its stake in shares of Insulet Corporation (NASDAQ: PODD) by 99.8% during the undefined quarter, according to the company in its most recent filing with the
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
07:00am, Tuesday, 16'th Dec 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will pres
4 Medical Device Stocks to Buy for Healthy Returns in 2026
08:56am, Monday, 15'th Dec 2025
ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod brand of products, has an
Geneos Wealth Management Inc. Sells 3,253 Shares of Insulet Corporation $PODD
05:28am, Sunday, 14'th Dec 2025
Geneos Wealth Management Inc. lowered its stake in shares of Insulet Corporation (NASDAQ: PODD) by 9.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securi
Frontier Capital Management Co. LLC Buys 2,683 Shares of Insulet Corporation $PODD
04:14am, Friday, 12'th Dec 2025
Frontier Capital Management Co. LLC boosted its stake in Insulet Corporation (NASDAQ: PODD) by 3.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange C
Here is Why Growth Investors Should Buy Insulet (PODD) Now
01:46pm, Wednesday, 10'th Dec 2025
Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements
09:01am, Monday, 08'th Dec 2025
Insulet Stock rises as the FDA clears key Omnipod 5 upgrades that enhance glucose targets and automation for its tubeless diabetes platform.
Insulet Corporation $PODD Shares Sold by Brown Advisory Inc.
04:54am, Monday, 08'th Dec 2025
Brown Advisory Inc. cut its stake in Insulet Corporation (NASDAQ: PODD) by 20.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Here's Why Insulet (PODD) is a Strong Growth Stock
10:46am, Thursday, 04'th Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
